|Articles|May 1, 2017
- Pharmaceutical Executive-05-01-2017
- Volume 37
- Issue 5
Pharmaceutical Executive, May 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Brand of the Year: A Retrospectiveover 9 years ago
Portfolio Management Health Checkover 9 years ago
Launch for Long-Term Successover 9 years ago
Merck’s Latest Shot Against Shinglesover 9 years ago
Measuring the Value of Prescription Drugsover 9 years ago
New Life in European Drug Pricing Spatover 9 years ago
Country Report: SwitzerlandAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
3
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
4
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
5